Paragon Bioservices, Inc., has announced that Mark Adams has joined the company as Vice President of Project Management. Mr. Adams will be responsible for directing Paragon’s Project Management team.
Mr. Adams comes to Paragon with a wealth of knowledge and over 30 years of industry experience at leading companies such as Shire Human Genetic Therapies, Genzyme Transgenics, Lonza Biologics and, most recently, at Cytovance Biologics. As VP of Program Management for Cytovance, Mark established a Program Management team that led cross-functional project teams, driving milestone deliverables for over 25 client process development and GMP manufacturing programs. He has extensive knowledge and experience in biological drug development. Mr. Adams holds a M.Sc. in Biochemistry from University College, Cork, Ireland.
“we are very please to welcome Mark to Paragon’s management team. He brings a proven track record of accomplishment in building project maangement systems and teams that drive commercial growth. We welcome his leadership and experience and are confident he will significantly strengthen our operation,” said Pete Buzy, President of Paragon.